mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
3e-08 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-08 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
4e-08 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-08 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
6e-08 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
6e-08 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
1e-07 |
mRNA |
GW-2580 |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
1e-07 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-07 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-07 |